REG - Cambridge Nutrition. - Posting of Annual Report and Notice of AGM

Cambridge Nutritional SciencesAnnouncement

15/08/2024 15:45

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240815:nRSO6540Aa&default-theme=true

RNS Number : 6540A  Cambridge Nutritional Sciences PLC  15 August 2024

 

CAMBRIDGE NUTRITIONAL SCIENCES PLC

 

("CNSL" or the "Company" or the "Group")

 

Posting of Annual Report and Notice of AGM

 

CNSL (AIM: CNSL), the specialist medical diagnostics company focused on
delivering a personalised approach to nutrition for better health, confirms
that the Notice of Annual General Meeting ('AGM') along with the Annual Report
and Accounts for the year ended 31 March 2024 have been posted to shareholders
on Thursday 15 August 2024 and will shortly be made available on the Company's
website at:

 

https://www.cnsplc.com/financials/

 

The Company's AGM will be held on Thursday 26 September 2024 at 11.00am at
Poets House, St Mary's Street, Ely, CB7 4EY.

 

Contacts:

 

 Cambridge Nutritional Sciences                                                                        www.cnsplc.com (http://www.cnsplc.com)
 plc
 Carolyn Rand, Non-Executive                                                                           investors@cnsplc.com
 Chair

 Cavendish Capital Markets                                                                             Tel: 020 7220 0500
 Limited
 Geoff Nash/Edward Whiley (Corporate Finance)
 Nigel Birks / Harriet Ward (ECM)

 

About Cambridge Nutritional Sciences plc

Cambridge Nutritional Sciences plc (AIM: CNSL) is the specialist medical
diagnostics company focused on delivering a personalised approach to nutrition
for better health.

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NOAQKPBQQBKDDFD